Predicting outcomes with pembrolizumab: a meta-analysis of pre-treatment hematological and clinical prognostic factors in advanced/metastatic urothelial carcinoma. (2025). Archivio Italiano Di Urologia E Andrologia, 97(2). https://doi.org/10.4081/aiua.2025.13880